openPR Logo
Press release

Alzheimer’s Drugs Market to Record Sturdy Growth by 2025

05-09-2018 08:29 PM CET | Health & Medicine

Press release from: Transparency Market Research

Alzheimer’s Drugs Market to Record Sturdy Growth by 2025

The global Alzheimer's Drugs Market has a huge scope of growth in developing nations on account of limited awareness about this disease in various underdeveloped nations. According to a report by Transparency Market Research (TMR), players within the market which are based in Europe and North America are expected to lead in the coming years on account of the widespread presence of treatment channels for Alzheimer's across nations such as the UK, Germany, Canada, and the US. Companies within the market that led in 2016 include: Allergan plc and Novartis AG. These two players have expanded their global market presence through acquisitions of emerging brands. Names of some of the other key players in the global Alzheimer’s drugs market include H Lundbeck A/S, Eisai Co Ltd, Daiichi Sankyo Company Limited, Merz Holding GmbH & Co KG, Ono Pharmaceutical Co Ltd, and Johnson & Johnson.

According to Transparency Market Research, the global market opportunity for Alzheimer's drugs is expected to scale to US$6.4 bn by 2025 after being worth US$3.6 bn in 2017, exhibiting a CAGR of 7.5% between 2017 and 2025. By geography, it is anticipated that North America will continue to remain in its leading position even in the years to come on account of the presence of several leading players. The presence of prominent players in the region has helped in easy distribution of treatment channels thereby helping the market to grow in this region.

The North American Alzheimer's drugs market is expected to rise from US$1.7 bn in 2017 to reach an evaluation of US$3 bn by 2025, expanding at a CAGR of 7.3% from 2017 to 2025. The report predicts that the Asia Pacific Alzheimer's drugs Market will expand at the highest pace, exhibiting an 8.6% CAGR between 2017 and 2025. The market in Asia Pacific is estimated to be worth US$2.3 bn in 2025 after being worth US$1.1 bn in 2017.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1245

Combined Drug Therapy and Memantine to Make Significant Contribution to Revenues

On the basis of drug class, it is expected that memantine which led in the past will continue to do so in the years to come. TMR also predicts that combined drug treatment will also contribute significantly to the revenue of the global Alzheimer's drugs market in the coming years on account of the increasing realization and awareness about the efficiency of combined therapy. The increasing availability of combined therapy is also expected to be a reason behind its increased demand.

Support Received from Governments in Developed Nations to Drive Growth of Alzheimer's Drugs Market

One of the most important factors boosting the growth of the global Alzheimer's drugs market is the increasing prevalence of this disease among the elderly in the developed nations in the West. This market also receives a healthy support from governments across developed nations on account of the rising occurrence of neurodegenerative diseases in these nations. This in turn has led to the development of new drugs and therapies which has helped in the development and growth of the global Alzheimer's drugs market subsequently. The atmosphere is especially conducive for the Alzheimer’s drugs market in North America. In addition to this, the increasing awareness about neurodegenerative diseases among the developing nations and Asia Pacific will also fuel the growth of the global Alzheimer's drugs market in the years to come.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1245

High Cost of Advanced Drugs to Restrict the Growth of Market in Cost-sensitive Countries in Asia Pacific

As a result of limited awareness about Alzheimer's disease in several countries in the southeast of Asia, the research infrastructure in this part of the world remains underdeveloped for Alzheimer's. In addition to this the high cost of advanced drugs for the treatment of Alzheimer's has also deterred the cost sensitive regions and underdeveloped nations in Asia Pacific from adopting these drugs. On a bright side however, things are changing and governments are increasingly supporting mental care infrastructure across several developing nations of Asia Pacific and this is expected to overcome the impact of the above mentioned restraint and help the market to grow in this region in the years to come.

View Report -

http://www.transparencymarketresearch.com/alzheimers-drugs-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer’s Drugs Market to Record Sturdy Growth by 2025 here

News-ID: 1045120 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Alzheimer

Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as